Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02934763Phase 4Unknown
Phase 4, randomised, double-blind trial of propranolol in opioid-induced hyperalgesia (OIH) (3 arms), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Postoperative opioid use in the post anesthesic care unit. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02934763.